Non-specific resistance mechanisms to listeriosis: Implications for experimental and naturally occurring infection

Immunological Reviews

Volumn 158, Issue , 1997, Pages 47-56

  Czuprynski, Charles J ^a   Haak Frendscho, Mary ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PROMEGA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL IMMUNITY; EXPERIMENTAL MODEL; INFECTION RESISTANCE; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGENS, BACTERIAL; CYTOKINES; GASTROINTESTINAL DISEASES; IMMUNITY, NATURAL; LISTERIA INFECTIONS; LIVER; MICE; MODELS, IMMUNOLOGICAL; NEUTROPHILS; T-LYMPHOCYTES;

EID: 0030769627     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb00991.x     Document Type: Review

References (120)

1. Mackaness GB. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med 1969;129:973-996.
2. Zinkernagel RM, et al. H2 restriction of cell-mediated immunity to an intracellular bacterium. J Exp Med 1977;145:1353-1367.
3. Kaufmann SHE. Specific Lyt 123 T cells are involved in protection against Listeria monocytogenes and in delayed type hypersensitivity to listerial antigens. J Exp Med 1979;150:1033-1038.
4. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
5. Portnoy DA, Chakraborty T, Goebel W, Cossart P. Molecular determinants of Listeria monocytogenes pathogenesis. Infect Immun 1992;60:1263-1267.
6. Kiderlen AF, Kaufmann SHE, Lohmann-Mathes ML. Protection of mice against the intracellular bacterium listeria monocytogenes by recombinant immune interferon. Eur J Immunol 1984;14:964-967.
7. Czuprynski CJ, Brown JF, Young RM, Cooley AJ, Kurtz RS. Effects of murine recombinant interleukin-1α on the host response to bacterial infection. J Immunol 1988;140:962-968.
8. Conlan JW, North RJ. Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium. J Exp Med 1991;174:741-744.
9. Czuprynski CJ, Brown JF, Maroushek N, Wagner RD, Steinberg H. Administration of anti-granulocyte MAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol 1994;152:1836-1846.
10. Gray ML, Killinger AH. Listeria monocytogenes and listeric infection. Bacteriol Rev 1966;30:309-371.
11. Farber JM, Peterkin PI. Listeria monocytogenes, a food-borne pathogen. Microbiol Rev 1991;55:476-511.
12. Schuchat A, Swaminathin B, Broome CV. Epidemiology of human listeriosis. Clin Microbiol Rev 1991;4:169-183.
13. Hitchins AD. Assessment of alimentary exposure to Listeria monocytogenes. Int J Food Microbiol 1996;30:71-85.
14. Tappero JW, et al. Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? JAMA 1995;273:1118-1122.
15. Zachar Z, Savage DC. Microbial interference and colonization of the murine gastrointestinal tract by Listeria monocytogenes. Infect Immun 1979;23:168-174.
16. MacDonald TT, Carter PB. Cell-mediated immunity of intestinal infection. Infect Immun 1980;18:516-523.
17. Czuprynski CJ, Balish E. Pathogenesis of Listeria monocytogenes for gnotobiotic rats. Infect Immun 1981;32:323-331.
18. Okamoto M, Nakane A, Minagawa T. Host resistance to an intragastric infection with Listeria monocytogenes in mice depends on cellular immunity and intestinal bacterial flora. Infect Immun 1994;62:3080-3085.
19. Golnazarian CA, Donnelly CW, Pintauro SJ, Howard, DB. Comparison of infectious dose of Listeria monocytogenes F5817 as determined for normal versus compromised C57B1/6J mice. J Food Prot 1989;52:696-701.
20. Schlech WF III, Chase DP, Badley A. A model of food-borne Listeria monocytogenes infection in the Sprague-Dawley rat using gastric inoculation: development and effect of gastric acidity on infective dose. Int J Food Microbiol 1993;18:15-24.
21. Marco AJ, et al. A microbiological, histopathological and immunohistological study of the intragastric inoculation of Listeria monocytogenes in mice. J Comp Pathol 1992;107:1-9.
22. Czuprynski CJ, Theisen C, Brown JF. Treatment with the antigranulocyte monoclonal antibody RB6-8C5 impairs resistance of mice to gastrointestinal infection with Listeria monocytogenes. Infect Immun 1996;64:3946-3949.
23. Roll JT, Czuprynski CJ. Hemolysin is required for extraintestinal dissemination of Listeria monocytogenes in intragastrically inoculated mice. Infect Immun 1990;58:3147-3150.
24. Portnoy DA. Innate immunity to a facultative intracellular bacterial pathogen. Infect Immun 1992;4:20-24.
25. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993;11:129-163.
26. Lane FC, Unanue ER. Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med 1972;135:1104-1112.
27. North RJ. The concept of the activated macrophage. J Immunol 1978;121:806-809.
28. Mackaness GB. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med 1969;129:973-992.
29. Buchmier N, Schreiber RD. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci USA 1985;82:7404-7408.
30. North RJ. Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. Cell Immunol 1973;7:166-176.
31. Beller DI, Kiely JM, Unanue ER. Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunological stimuli. J Immunol 1980;124:1426-1432.
32. Steigbigel RT, Lambert LH, Remington JS. Phagocytic and bactericidal properties of normal human monocytes. J Clin Invest 1974;53:131-142.
33. Peterson PK, Verhoef J, Schmeling D, Quie PG. Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes. J Infect Dis 1977;136:502-509.
34. Czuprynski CJ, Campbell PA, Henson PM. Killing of Listeria monocytogenes by human neutrophils and monocytes, but not monocyte-derived macrophages. J Reticuloendothel Soc 1983;34:29-44.
35. Czuprynski CJ, Henson PM, Campbell PA. Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice. J Leukoc Biol 1984;35:193-208.
36. Gervais F, Stevenson M, Skamene E. Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus. J Immunol 1984;132:2078-2083.
37. Czuprynski CJ, Canono BP, Henson PM, Campbell PA. Genetically determined resistance to listeriosis is associated with increased accumulation of inflammatory neutrophils and macrophages which have enhanced listericidal activity. Immunology 1985;55:511-518.
38. Vidal S, Gros P, Skamene E. Natural resistance to infection with intracellular parasites - molecular genetic identification of Nramp as the Bcg/Ity/Lsh locus. J Leukoc Biol 1995;58:382-390.
39. Havell EA. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol 1989;143:2894-2899.
40. Gregory SH, Barczynski LK, Wing EJ. Effector function of hepatocytes and Kupffer cells in the resolution of systemic bacterial infections. J Leukoc Biol 1992;51:421-424.
41. Rosen, H, Gordon S, North RJ. Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. J Exp Med 1989;170:27-37.
42. Conlan JW, North RJ. Monoclonal antibody NIMP-R10 directed against the CD11b chain of the type 3 complement receptor can substitute for monoclonal antibody 5C6 to exacerbate listeriosis by preventing the focusing of myelomonocytic cells at infectious foci in the liver. J Leukoc Biol 1992;52:130-132.
43. Conlan J, North RJ. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med 1994;179:259-268.
44. Conlan W, North R. Neutrophil mediated lysis of infected hepatocytes. Am Soc Microbiol News 1993;59: 563-567.
45. Rogers HW, Unanue ER. Neutrophils are involved in acute, non-specific resistance to Listeria monocytogenes in mice. Infect Immun 1993;61:5090-5096.
46. Appelberg R, Castro AG, Silva MT. Neutrophils as effector cells of T-cell-mediated, acquired immunity in murine listeriosis. Immunology 1994;83:302-307.
47. Rakhmilevich AL. Neutrophils are essential for resolution of primary and secondary infection with Listeria monocytogenes. J Leukoc Biol 1995;57:827-831.
48. Czuprynski CJ, Brown JF, Wagner RD, Steinberg H. Administration of antigranulocyte monoclonal antibody RB6-8C5 prevents expression of acquired resistance to Listeria monocytogenes infection in previously immunized mice. Infect Immun 1994;62:5161-5163.
49. Boury NM, Czuprynski CJ. Listeria monocytogenes infection increases neutrophil adhesion and damage to a murine hepatocyte cell line. Immunol Lett 1995;46:111-116.
50. Rogers HW, Callery MP, Deck B, Unanue ER. Listeria monocytogenes induces apoptosis of infected hepatocytes. J Immunol 1996;156:679-684.
51. Gregory SH, Wing EJ. IFN-γ inhibits the replication of Listeria monocytogenes in hepatocytes. J Immunol 1993;151:1401-1409.
52. Szalay G, Hess J, Kaufmann SHE. Restricted replication of Listeria monocytogenes in a gamma interferon-activated murine hepatocyte cell line. Infect Immun 1995;63:3187-3195.
53. Haponsaph R, Czuprynski CJ. Inhibition of the multiplication of Listeria monocytogenes in a murine hepatocyte cell line (ATCC T1B73) by IFN-γ and TNF-α. Microb Pathog 1996;20:287-295.
54. Nakane A, Minagawa T, Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against listeria monocytogenes infection. Infect Immun 1988;56:2563-2569.
55. Nakane A, et al. Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect Immun 1989;57:3331-3337.
56. Roll JT, Young KM, Kurtz RS, Czuprynski CJ. Human rTNFα augments anti-bacterial resistance in mice: potentiation of its effects by recombinant human rIL-1α. Immunology 1990;69:316-322.
57. Langermans JAM, Van Der Hulst MEB, Nibbering PH, Van Furth R. Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice. Infect Immun 1992;60:5107-5112.
58. Kurtz RS, Czuprynski CJ. Separate and combined effects of recombinant interleukin-1α and interferon-γ on antibacterial resistance. Infect Immun 1989;57:553-558.
59. Van Der Meer JWM, Vogels MTE, Kullberg BJ. Interleukin-1 and related proinflammatory cytokines in the treatment of bacterial infections in neutropenic and non-neutropenic animals. Biotherapy 1994;7:161-167.
60. Demuth A, Goebel W, Beuscher HU, Kuhn M. Differential regulation of cytokine and cytokine receptor mRNA expression upon infection of bone marrow-derived macrophages with Listeria monocytogenes. Infect Immun 1996;64:3475-3483.
61. Iizawa Y, Brown JF, Czuprynski CJ. Early expression of cytokine mRNA in mice infected with Listeria monocytogenes. Infect Immun 1992;60:4068-4073.
62. Wagner RD, Czuprynski CJ. Cytokine mRNA expression in livers of mice infected with Listeria monocytogenes. J Leukoc Biol 1993;53:525-531.
63. Movat HZ, Burrowes CE, Cybulsky MI, Dinarello CA. Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Am J Pathol 1987;129:463-476.
64. Ashkenazi A, Capon DJ, Ward RHR. Immunoadhesins. Int Rev Immunol 1993;10:219-227.
65. Havell EA, Moldawer LL, Helfgott D, Killian PL, Sehgal PB. Type I IL-1 receptor blockade exacerbates murine listeriosis. J Immunol 1992;148:1486-1492.
66. Haak-Frendscho M, Marsters SA, Chamow SM, Peers DH, Simpson NJ, Ashkenazi A. Inhibition of interferon-γ by an interferon-γ receptor immunoadhesin. Immunology 1993;79:594-599.
67. Pitti RM, et al. Molecular and biological properties of an interleukin-1 receptor immunoadhesin. Mol Immunol 1994;31:1345-1351.
68. Hirsch E, Irikura VM, Paul SM, Hirsh D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 1996;93: 11008-11013.
69. Haak-Frendscho M, Kurtz RS, Czuprynski CJ. rIL-1α enhances adoptive transfer of resistance to Listeria monocytogenes infection. Microb Pathog 1991;10:385-392.
70. Gregory SH, Jiang X, Wing EJ. Lymphokine-activated killer cells lyse Listeria-infected hepatocytes and produce elevated quantities of interferon-gamma. J Infect Dis 1996;174:1073-1079.
71. Kratz SS, Kurlander RJ. Characterization of the pattern of inflammatory cell influx and cytokine production during the murine host response to Listeria monocytogenes. J Immunol 1988;141:598-606.
72. Liu W, Kurlander RJ. Analysis of the interrelationship between IL-12, TNF-α, and IFN-γ production during murine listeriosis. Cell Immunol 1995;163:260-267.
73. Huang S, et al. Immune response in mice that lack the interferon-γ receptor. Science 1993;259:1693-1694.
74. Havell EA, Sehgal PB. Tumor necrosis factor-independent IL-6 production during murine listeriosis. J Immunol 1991;146:756-761.
75. Czuprynski CJ, Haak-Frendscho M, Maroushek N, Brown JF. Effects of human interleukin-6 alone and in combination with interleukin-1α and tumor necrosis factor α, on antibacterial resistance in mice. Antimicrob Agents Chemother 1992;36: 68-70.
76. Liu Z, Simpson RJ, Cheers C. Role of IL-6 in activation of T cells for acquired cellular resistance to Listeria monocytogenes. J Immunol 1994;152:5375-5380.
77. Liu Z, Simpson RJ, Cheers C. Role of interleukin-6 in T-cell activation during primary and secondary infection with Listeria monocytogenes. Infect Immun 1995;63:2790-2792.
78. Dalrymple SA, et al. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 1995;63:2262-2268.
79. Kopf M, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368:339-342.
80. Cox G, Gauldie J. Structure and function of interleukin-6. In: Remick D, Kunkel S, eds. Cytokines in Health and Disease. New York: Marcel Dekker; 1991. p.97-120.
81. Haak-Frendscho M, Young KM, Czuprynski CJ. Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen Listeria monocytogenes. Infect Immun 1989;57:3014-3021.
82. Haak-Frendscho M, Czuprynski CJ. Use of recombinant interleukin-2 to enhance adoptive transfer of resistance to Listeria monocytogenes infection. Infect Immun 1992;60:1406-1414.
83. Haak-Frendscho M, Brown JF, Iizawa Y, Wagner RD, Czuprynski CJ. Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J Immunol 1992;148:3978-3985.
84. Iizawa Y, Czuprynski CJ. Effects of administration of murine recombinant IL-4 on the resistance of mice to Listeria monocytogenes infection. Immunol Lett 1992;32:185-190.
85. Szalay G, Ladel CH, Blum C, Kaufmann SH. IL-4 neutralisation or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice. J Immunol 1996;157:4746-4750.
86. Blauer F, Groscurth P, Schneemann M, Schoedon G, Schaffner A. Modulation of the antilisterial activity of human blood-derived macrophages by activating and deactivating cytokines. J Interferon Cytokine Res 1995;15:105-114.
87. Meier-Osusky I, Schoedon G, Blauer F, Schneemann M, Schaffner A. Comparison of the antimicrobial activity of deactivated human macrophages challenged with Aspergillus fumigatus and Listeria monocytogenes. J Infect Dis 1996;174:651-654.
88. Kelly JP, Bancroft GJ. Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur J Immunol 1996;26:356-364.
89. Wagner RD, Maroushek NM, Brown JF, Czuprynski CJ. Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect Immun 1994;62:2345-2353.
90. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198-200.
91. Hsieh B, Schrenzel MD, Mulvania T, Lepper HD, DiMolfetto-Landon L, Ferrick DA. In vivo cytokine production in murine listeriosis. Evidence for immunoregulation by gamma delta+ T cells. J Immunol 1996;156:232-237.
92. Locksley RM. Interleukin 12 in host defense against microbial pathogens. Proc Natl Acad Sci USA 1993;90:5879-5880.
93. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993;90:3725-3729.
94. Skeen MJ, Miller MA, Shinnick TM, Ziegler HK. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol 1996;156:1196-1206.
95. Song F, Matsuzake G, Mitsuyama M, Nomoto K. Differential effects of viable and killed bacteria on IL-12 expression of macrophages. J Immunol 1996;156:2979-2984.
96. Wagner RD, Steinberg H, Brown JF, Czuprynski CJ. Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microb Pathog 1994;17:175-186.
97. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER. Neutralisation of IL-12 decreases resistance to Listeria in SCID and CB17 mice. J Immunol 1994;152:1883-1887.
98. Miller MA, Skeen MJ, Ziegler HK. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J Immunol 1995;155:4815-4828.
99. Miller MA, Skeen MJ, Ziegler HK. Protective immunity to Listeria monocytogenes elicited by immunization with heat-killed Listeria and IL-12. Potential mechanism of IL-12 adjuvanticity. Ann N Y Acad Sci 1996;797:207-227.
100. Farber JM, Daley E, Coates F, Beausoleil N, Fournier J. Feeding trials of Listeria monocytogenes with a nonhuman primate model. J Clin Microbiol 1991;29:2606-2608.
101. Husu JR, Beery JT, Nurmi E, Doyle MP. Fate of Listeria monocytogenes in orally dosed chicks. Int J Food Microbiol 1990;11:259-270.
102. Lammerding AM, Glass KA, Gendron-Fitzpatrick A, Doyle MP. Determination of virulence of different strains of Listeria monocytogenes and Listeria innocua by oral inoculation of pregnant mice. Appl Environ Microbiol 1992;58: 3991-4000.
103. Miller JK, Burns J. Histopathology of Listeria monocytogenes after oral feeding to mice. Appl Microbiol 1970;19:772-775.
104. Kemenes F. Pathogenicity of Listeria monocytogenes in the rat. Acta Microbiol Acad Sci Hung 1972;19: 429-432.
105. Czuprynski CJ. Listeria. In: Gyles CL, Thoen CO, eds. Pathogenesis of bacterial infections in animals. Ames, IA: Iowa State University Press; 1993. p.70-79.
106. Redline RW, Lu CY. Role of local immunosuppression in murine fetoplacental listeriosis. J Clin Invest 1987;79:1234-1241.
107. Portnoy DA, Schreiber RD, Connelly P, Tilney LG. γ interferon limits access of Listeria monocytogenes to the macrophage cytoplasm. J Exp Med 1989;170:2141-2146.
108. Gaillard J-L, Finlay BB. Effect of cell polarization and differentiation on entry of Listeria monocytogenes into the enterocyte-like Caco-2 cell line. Infect Immun 1996;64:1299-1308.
109. Meyer DH, Bunduki M, Beliveau CM, Donnelly CW. Differences in invasion and adherence of Listeria monocytogenes with mammalian gut cells. Food Microbiol 1992;9:115-126.
110. Mengaud J, Ohayon H, Gounon P, Mege R-M, Cossart P. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell 1996;84:923-932.
111. Lingnau A, et al. Expression of the Listeria monocytogenes EGD inlA and inlB genes, whose products mediate bacterial entry into tissue culture cell lines, by PrfA-dependent and -independent mechanisms. Infect Immun 1995;63:3896-3903.
112. Lebrun M, Mengaud J, Ohayon H, Nato F, Cossart P. Internalin must be on the bacterial surface to mediate entry of Listeria monocytogenes into epithelial cells. Mol Microbiol 1996;21:579-592.
113. Racz P, Tenne K, Mero E. Experimental Listeria enteritis: I. An electron microscopic study of the epithelial phase in experimental Listeria infection. Lab Invest 1972;26:694-700.
114. Ohtsuka K, Kazunari A, Watanabe H, Kimura M, Asakura H, Abo T. Unique order of the lymphocyte subset induction in the liver and intestine of mice during Listeria monocytogenes infection. Cell Immunol 1995;161:112-124.
115. Lopez MB, et al. Serological response in rabbits to Listeria monocytogenes after oral or intragastric inoculation. FEMS Immunol Med Microbiol 1993;7: 131-134.
116. Yamamoto S, Russ F, Teixeira HC, Conradt P, Kaufmann SHE. Listeria monocytogenes-induced gamma interferon secretion by intestinal intraepithelial γ/δ T-lymphocytes. Infect Immun 1993;61:2154-2161.
117. Ishikawa H, Li Y, Abeliovich A, Yamamoto S, Kaufmann SHE, Tonegawa S. Cytotoxic and interferon γ-producing activities of γδ T cells in the mouse intestinal epithelium are strain dependent. Proc Natl Acad Sci USA 1993;90:8204-8208.
118. Schafer R, Portnoy DA, Brassell SA, Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J Immunol 1992;149:53-59.
119. Milon G, Cossart P. Live recombinant Listeria monocytogenes as an immunotherapeutic agent for experimental tumors. Trends Microbiol 1995;3:451-453.
120. Shen H, Slifka MK, Matloubian M, Jensen ER, Ahmed R, Miller JF. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. J Immunol 1995;92:3987-3991.